Search
Close this search box.
Search
Close this search box.

[email protected]

‫مساهمة إندونيسيا في مجال اللقاحات: تُعزز كل من Bio Farma وDCVMN مرونة النظم الصحية من خلال الشراكة العالمية

باندونغ، إندونيسيا, Oct. 22, 2025 (GLOBE NEWSWIRE) — أدّت إندونيسيا دورًا استراتيجيًا ومستمرًا في شبكة DCVMN من خلال شركة PT Bio Farma (Persero)، ساعيةً إلى ضمان الوصول العادل إلى لقاحات آمنة وفعّالة وعالية الجودة وبأسعار مناسبة. ومنذ تأسيس شبكة DCVMN في عام 2000، كانت Bio Farma أحد المحرّكات الرئيسية لتعزيز

Read More

Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year

ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug product facility has been named “Manufacturer of the Year” by the Massachusetts Legislative Manufacturing Caucus. The award was presented at the 10th Annual

Read More

Indonesia’s Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership

BANDUNG, Indonesia, Oct. 21, 2025 (GLOBE NEWSWIRE) — Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers’ Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN’s founding in 2000, Bio Farma has been a

Read More